The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Business

Chick-fil-A announces shift from ‘no antibiotics’ in chicken pledge

by admin March 27, 2024
March 27, 2024
Chick-fil-A announces shift from ‘no antibiotics’ in chicken pledge

Chick-fil-A says it will no longer adhere to its pledge of serving antibiotic-free chicken.

In a statement released Monday, the fast-food company said that starting this spring it would serve chicken that was free only of antibiotics ‘important to human medicine,’ or those commonly used to treat people.

It said its poultry going forward may have been raised with animal antibiotics, though ‘only if the animal and those around it were to become sick.’ The chicken will continue to be free of artificial preservatives, steroids and added hormones, it said.

Chick-fil-A first announced its no-antibiotics pledge in 2014.

But amid an avian-flu outbreak that devastated poultry supplies nationwide, chicken farmers who’d previously sought to avoid antibiotics have been forced to turn to them. Last July, food processing giant Tyson announced it was ending its ‘no antibiotics ever’ pledge. Poultry producer Perdue Farms still has its pledge in place, while rival Pilgrim’s Pride says it uses some.

While world health officials have long raised concerns about the potential of any antibiotics in food to degrade the human body’s immunity to disease treatments, the Food and Drug Administration has said it is more concerned about the use of antibiotics commonly prescribed to humans than ones used to treat animal illnesses.

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Trump is selling $60 Bibles with ‘God Bless the U.S.A.’ singer Lee Greenwood
next post
Home price growth is back at pre-pandemic levels. Here’s what that means for buyers and sellers.

Related Posts

Walmart issues recall of apple juice sold in...

August 29, 2024

Fortnite applies to launch on Apple’s App Store...

May 12, 2025

Trump Media shares end week down nearly 20%,...

April 13, 2024

Trump-Bezos call sets stage for tense earnings report...

May 1, 2025

Anne Wojcicki to buy back 23andMe and its...

June 16, 2025

Fox reveals plans to launch subscription streaming service...

February 5, 2025

Starbucks to pay about $35M to NYC workers...

December 3, 2025

How Fanatics is teaching business acumen to pro...

June 25, 2025

JPMorgan Chase CEO Jamie Dimon on Trump tariffs: ‘Get...

January 23, 2025

Workers earning up to $58K a year could...

April 26, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The Real Drivers of This Market: AI, Semis & Robotics

      December 31, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      December 31, 2025
    • Sen Jim Justice says Republicans are ‘lousy’ at knowing what everyday Americans think about healthcare

      December 31, 2025
    • Anti-Iran regime protests grow across country as Trump admin boosts demonstrators offering support

      December 31, 2025
    • DOJ’s second-in-command could be central to ‘vindictive’ prosecution of Abrego Garcia, judge rules

      December 31, 2025
    • Putin residence drone attack dismissed as ‘implausible’ as Ukraine accusations mount

      December 31, 2025

    Categories

    • Business (1,444)
    • Politics (5,381)
    • Stocks (1,863)
    • Uncategorized (45)
    • World News (1,437)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved